Showing results (371-380 of 2,469) with videos related to

Sort By:
Pageof 247
The Journal of Headache and Pain|March 14, 2018
The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular systemKarl Messlinger
The Journal of Headache and Pain|March 19, 2020
Migraine, headache, and mortality in women: a cohort studyJessica L Rohmann, Pamela M Rist, Julie E Buring, et al.
The Journal of Headache and Pain|March 20, 2020
The cerebellum is associated with 2-year prognosis in patients with high-frequency migraineHung-Yu Liu, Pei-Lin Lee, Kun-Hsien Chou, et al.
The Journal of Headache and Pain|September 15, 2020
Impaired effective functional connectivity of the sensorimotor network in interictal episodic migraineurs without auraHeng-Le Wei, Jing Chen, Yu-Chen Chen, et al.
The Journal of Headache and Pain|January 4, 2020
White matter changes in chronic and episodic migraine: a diffusion tensor imaging studyÁlvaro Planchuelo-Gómez, David García-Azorín, Ángel L Guerrero, et al.
The Journal of Headache and Pain|January 9, 2020
ICHD-3 is significantly more specific than ICHD-3 beta for diagnosis of migraine with aura and with typical auraCarl H Göbel, Sarah C Karstedt, Thomas F Münte, et al.
The Journal of Headache and Pain|October 22, 2020
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMABGiuseppe Tringali, Catello Vollono, Paolo Calabresi, et al.
The Journal of Headache and Pain|October 17, 2020
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?Rosaria Greco, Roberto De Icco, Chiara Demartini, et al.
The Journal of Headache and Pain|January 18, 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.
The Journal of Headache and Pain|February 15, 2019
Correction to: A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headachesD García-Azorin, N Yamani, L M Messina, et al.
Pageof 247